NCT00092209View on ClinicalTrials.gov

Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)

PHASE3CompletedINTERVENTIONAL

Enrollment

840

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions

Hypertension

Interventions

DRUG

MK0954A, hydrochlorothiazide (+) losartan potassium

DRUG

Comparator: placebo, losartan, hydrochlorothiazide

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00092209 - Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302) | Biotech Hunter | Biotech Hunter